Clinical Trials Directory

Trials / Completed

CompletedNCT02314754

Outpatient Medical Abortion With Mifepristone and Misoprostol Through 77 Days of Gestation

Outpatient Medical Abortion With Mifepristone and Misoprostol Through 77 Days of Gestation: A Non-inferiority Trial

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
719 (actual)
Sponsor
Gynuity Health Projects · Academic / Other
Sex
Female
Age
11 Years – 55 Years
Healthy volunteers
Accepted

Summary

To demonstrate non-inferiority of the efficacy of 200 mg mifepristone followed in 24 to 48 hours by 800 µg buccal misoprostol in outpatient medical abortion services among women 71-77 days' compared to women 64-70 days' LMP.

Conditions

Interventions

TypeNameDescription
DRUGMifepristone followed by misoprostol 24-48 hours later200mg oral mifepristone and 800mcg buccal misoprostol 24-48 hours after mifepristone

Timeline

Start date
2014-12-01
Primary completion
2016-04-01
Completion
2016-04-01
First posted
2014-12-11
Last updated
2016-07-14

Locations

8 sites across 5 countries: United States, Azerbaijan, Georgia, Mexico, Vietnam

Source: ClinicalTrials.gov record NCT02314754. Inclusion in this directory is not an endorsement.